The discovery of a novel prototype small molecule TLR7 agonist for the treatment of hepatitis C virus infection-Reference-Cited by-同舟云学术

The discovery of a novel prototype small molecule TLR7 agonist for the treatment of hepatitis C virus infection

Published:2011 Issue:3 Volume:2 Page:185-189
ISSN:2040-2503
Container-title:Med. Chem. Commun.
language:en
Short-container-title:Med. Chem. Commun.

Author:

Pryde David C.,Tran Thien-Duc,Jones Peter,Parsons Gemma C.,Bish Gerwyn,Adam Fiona M.,Smith Mya C.,Middleton Donald S.,Smith Nick N.,Calo Frederick,Hay Duncan,Paradowski Michael,Proctor Katie J. W.,Parkinson Tanya,Laxton Carl,Fox David N. A.,Horscroft Nigel J.,Ciaramella Giuseppe,Jones Hannah M.,Duckworth Jonathan,Benson Neil,Harrison Anthony,Webster Rob

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2011/MD/C0MD00197J

Reference17 articles.

1. Innate Immune Recognition

2. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA

3. Toll-Like Receptors

4. The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults

5. Crystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors;Journal of Medicinal Chemistry;2021-06-10

2. Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles;RSC Medicinal Chemistry;2021

3. Latest Advances in Small Molecule TLR 7/8 Agonist Drug Research;Current Topics in Medicinal Chemistry;2019-11-18

4. Balancing Inflammation: Computational Design of Small-Molecule Toll-like Receptor Modulators;Trends in Pharmacological Sciences;2017-02

5. Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma;Journal of Medicinal Chemistry;2016-02-10